Plan African market entry and trial strategy with better evidence.
Kapsule helps pharma teams understand burden, patient availability, and market opportunity across African countries before committing budget.
Questions Kapsule can help you answer
Kapsule is most useful when teams need a faster, more evidence-based way to make African market decisions.
Which countries should we prioritize for a therapy area, and what evidence supports that choice?
How large and accessible are relevant patient populations across target markets?
Where do trial feasibility and commercial opportunity overlap most clearly?
How do we reduce time spent stitching together fragmented local market inputs?
Sample output: market and trial feasibility
An illustrative example of the structured intelligence Kapsule delivers.
Which markets have the patient depth and site readiness for your next study?
South Africa leads on diagnostic infrastructure; Nigeria has the largest patient pool but lower per-capita capacity. Kenya balances both. Recommended for Phase III feasibility.
How Kapsule helps
Each workflow is designed to turn fragmented local inputs into clearer decisions.
Market sizing
Compare burden, demand, and care patterns across countries before committing commercial resources.
Trial feasibility
Estimate patient depth and likely site potential earlier in the planning cycle.
Portfolio planning
Support strategy, market access, and business-development teams with one Africa-focused intelligence layer.
Why teams choose Kapsule
The difference is not just data access. It is Africa-specific context that helps teams act faster.
Africa-specific data infrastructure rather than a generic global overlay
Patient and market intelligence in one workflow
Useful for strategy, medical, access, and business-development teams
A practical guide to African trial planning and feasibility
See which African markets are worth prioritizing next.
Start with the guide, then talk to the team if you want to explore a specific trial or feasibility question.